Trial NCT01127893

View at ClinicalTrials.gov 
Org. Study IDs: A4091032
Secondary IDs: SAFETY EXTENSION OF 1027

Last trial update was posted on 2021-03-10

MeSH Interventions

Tanezumab

MeSH Conditions

Osteoarthritis

Other Conditions


Stopping Reasons

See termination reason in detailed description.

Limitations And Caveats

Due to the US FDA imposed clinical hold, enrollment and further dosing with study medication was stopped prematurely, only 1 participant was enrolled and the study was terminated early. Designation of outcomes as primary, secondary based on study team input as study did not specify them as primary or secondary.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID